肿瘤坏死因子配体超家族成员9(TNFSF9)重组蛋白
英文名称: Recombinant Tumor Necrosis Factor Ligand Superfamily, Member 9 (TNFSF9)
型号:null    产品货号: YB934Mu014
价格:请致电:010-57128832,18610462672
品牌: 中国/美国

 肿瘤坏死因子配体超家族成员9(TNFSF9)重组蛋白

YB934Mu014
Recombinant Tumor Necrosis Factor Ligand Superfamily, Member 9 (TNFSF9)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
10th Edition (Revised in Jan, 2014)
 肿瘤坏死因子配体超家族成员9(TNFSF9)重组蛋白[ PROPERTIES ]
Residues: Ala42~Ser253
Tags: Two N-terminal Tags, His-tag and T7-tag
Accession: P41273
Host: E. coli
Subcellular Location: Membrane; Single-pass
type II membrane protein.
Purity: >95%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in PBS,
pH7.4, containing 5% trehalose, 0.01% sarcosyl.
Predicted isoelectric point: 8.1
Predicted Molecular Mass: 25.8kDa
 肿瘤坏死因子配体超家族成员9(TNFSF9)重组蛋白Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile PBS, pH7.2-pH7.4.
[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
precipitation were observed. (Referring from China Biological Products Standard,
which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
 肿瘤坏死因子配体超家族成员9(TNFSF9)重组蛋白[ SEQUENCES ]
The sequence of the target protein is listed below.
AAACAVFLA CPWAVSGARA SPGSAASPRL REGPELSPDD PAGLLDLRQG MFAQLVAQNV
LLIDGPLSWY SDPGLAGVSL TGGLSYKEDT KELVVAKAGV YYVFFQLELR RVVAGEGSGS
VSLALHLQPL RSAAGAAALA LTVDLPPASS EARNSAFGFQ GRLLHLSAGQ RLGVHLHTEA
RARHAWQLTQ GATVLGLFRV TPEIPAGLPS PRS